PAPER Tan J, Town T, Paris D, Placzek A, Parker T, Crawford F, Yu H, Humphrey J, Mullan M
SEARCH RESULTS
331171 RESULTS
Joe Yates
United States
PAPER Clayton JA, Collins FS
Policy: NIH to balance sex in cell and animal studies.
Nature. 2014 May 15;509(7500):282-3. PubMed: 24834516Esther Stroo
Groningen, Netherlands
PAPER Kim S, Lee Y, Cho J
Korean red ginseng extract exhibits neuroprotective effects through inhibition of apoptotic cell death.
Biol Pharm Bull. 2014;37(6):938-46. PubMed: 24882407PAPER Lasagna-Reeves CA, Sengupta U, Castillo-Carranza D, Gerson JE, Guerrero-Munoz M, Troncoso JC, Jackson GR, Kayed R
The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes.
Acta Neuropathol Commun. 2014 May 29;2:56. PubMed: 24887264PAPER Ouzounoglou E, Kalamatianos D, Emmanouilidou E, Xilouri M, Stefanis L, Vekrellis K, Manolakos ES
In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis.
BMC Syst Biol. 2014 May 13;8:54. PubMed: 24885905PAPER Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi K, Spencer B, Price DL, Patrick C, Desplats P, Masliah E
Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5- implications for dementia with Lewy bodies.
Mol Neurodegener. 2014 May 19;9:18. PubMed: 24885390PAPER Lai Y, Kim S, Varkey J, Lou X, Song JK, Diao J, Langen R, Shin YK
Nonaggregated α-synuclein influences SNARE-dependent vesicle docking via membrane binding.
Biochemistry. 2014 Jun 24;53(24):3889-96. Epub 2014 Jun 13 PubMed: 24884175PAPER Knight AL, Yan X, Hamamichi S, Ajjuri RR, Mazzulli JR, Zhang MW, Daigle JG, Zhang S, Borom AR, Roberts LR, Lee SK, DeLeon SM, Viollet-Djelassi C, Krainc D, O'Donnell JM, Caldwell KA, Caldwell GA
The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.
Cell Metab. 2014 Jul 1;20(1):145-57. Epub 2014 May 29 PubMed: 24882066PAPER Ayers JI, Xu G, Pletnikova O, Troncoso JC, Hart PJ, Borchelt DR
Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.
Acta Neuropathol Commun. 2014 May 14;2:55. PubMed: 24887207PAPER Mancuso R, Del Valle J, Morell M, Pallás M, Osta R, Navarro X
Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
Orphanet J Rare Dis. 2014 May 21;9:78. PubMed: 24885036PAPER Italiani P, Carlesi C, Giungato P, Puxeddu I, Borroni B, Bossù P, Migliorini P, Siciliano G, Boraschi D
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.
J Neuroinflammation. 2014 May 23;11:94. PubMed: 24884937PAPER Walls KC, Ager RR, Vasilevko V, Cheng D, Medeiros R, LaFerla FM
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice.
Neurosci Lett. 2014 Jul 11;575:96-100. Epub 2014 Jun 2 PubMed: 24887583PAPER Pedrós I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, Auladell C, Pallàs M, Vázquez-Carrera M, Casadesús G, Folch J, Camins A
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Biochim Biophys Acta. 2014 Sep;1842(9):1556-66. Epub 2014 Jun 2 PubMed: 24887203Current Filters
No filters selected